- Home
- RNXT vs INKT Comparison
RNXT vs INKT Comparison
Compare RNXT & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- INKT
- Stock Information
- Founded
- RNXT 2012
- INKT 2017
- Country
- RNXT United States
- INKT United States
- Employees
- RNXT N/A
- INKT N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- INKT Medicinal Chemicals and Botanical Products
- Sector
- RNXT Health Care
- INKT Health Care
- Exchange
- RNXT Nasdaq
- INKT Nasdaq
- Market Cap
- RNXT 33.8M
- INKT 28.5M
- IPO Year
- RNXT 2021
- INKT 2021
- Fundamental
- Price
- RNXT $1.50
- INKT $0.88
- Analyst Decision
- RNXT Strong Buy
- INKT Strong Buy
- Analyst Count
- RNXT 2
- INKT 2
- Target Price
- RNXT $6.50
- INKT $6.50
- AVG Volume (30 Days)
- RNXT 101.2K
- INKT 216.6K
- Earning Date
- RNXT 11-13-2024
- INKT 11-14-2024
- Dividend Yield
- RNXT N/A
- INKT N/A
- EPS Growth
- RNXT N/A
- INKT N/A
- EPS
- RNXT N/A
- INKT N/A
- Revenue
- RNXT N/A
- INKT N/A
- Revenue This Year
- RNXT N/A
- INKT N/A
- Revenue Next Year
- RNXT N/A
- INKT N/A
- P/E Ratio
- RNXT N/A
- INKT N/A
- Revenue Growth
- RNXT N/A
- INKT N/A
- 52 Week Low
- RNXT $0.77
- INKT $0.46
- 52 Week High
- RNXT $1.86
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- RNXT 64.78
- INKT 59.64
- Support Level
- RNXT $1.26
- INKT $0.74
- Resistance Level
- RNXT $1.60
- INKT $0.91
- Average True Range (ATR)
- RNXT 0.12
- INKT 0.12
- MACD
- RNXT 0.01
- INKT 0.01
- Stochastic Oscillator
- RNXT 72.22
- INKT 51.99
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.